Women with polycystic ovary syndrome are characterized by obesity, menstruation irregularity, hirsutism and infertility, and prevalent with cardiometabolic comorbidities, but population-based studies on the risk of developing coronary artery disease are limited. From claims data of the Taiwan National Health Insurance, we identified 8048 women with polycystic ovary syndrome aged 15-49 years new...

PURPOSE To evaluate the prevalence of common mental disorders in women diagnosed with polycystic ovary syndrome as compared with paired controls without this syndrome. METHODS Cross-sectional study with a Control Group examining women between the ages of 18 and 30 who did not use antidepressants and who sought the Gynecology Service of the researched sites. For every woman diagnosed with the ...

The Key Role of Inflammation and Oxidative Stress in Polycystic Ovary Syndrome Testicular Torsion: A Review Their Induction Rat Model

OBJECTIVE To compare lipid profile in lean and obese women with polycystic ovary syndrome with normal weight and obese controls. METHOD The case-control study was conducted at the Department of Chemical Pathology, Liaquat National Hospital, Karachi, from March 2006 to April 2007. It comprised 50 cases of polycystic ovary syndrome along with 50 healthy controls matching for age, gender and wei...

BACKGROUND Metformin is effective for the treatment of polycystic ovary syndrome, but conflicting results regarding its effect on adipocytokine levels (adiponectin, resistin, visfatin, and leptin) in patients with polycystic ovary syndrome receiving metformin treatment have been reported. To provide high-quality evidence about the effect of metformin treatment on adipocytokines in patients with...

The polycystic ovary syndrome is the most common endocrinological disorder of reproductive age women with a prevalence of 5 to 8 %. The most common diagnostic criteria used for polycystic ovary syndrome are oligo- or an-ovulation, clinical and/ or biochemical signs of hyperandrogenism and polycystic ovaries. Hyperandrogenism results in increased estrogen levels and lack of cyclic progesterone d...

Due to genetic heterogeneity and variable diagnostic criteria, genetic studies of polycystic ovary syndrome are particularly challenging. Furthermore, lack of sufficiently large cohorts limits the identification of susceptibility genes contributing to polycystic ovary syndrome. Here, we carried out a systematic search of studies deposited in the Gene Expression Omnibus database through August 3...

background: polycystic ovary syndrome (pcos) is the most common endocrine disorder in reproductive women. nearly 10% of young women in this period involved. although factors such as insulin resistance, hyper insulinemia, obesity and dietary are suggested to be associated with pcos, cause of pcos is not completely understood. dairy products (a key component of the usual diet) of participants can...

objective: polycystic ovary syndrome (pcos) is one of the most common endocrine disorders in women. metformin is a biguanide commonly used to improve pcos symptoms. effect of metformin on the levels of serum homocysteine (hcy) in pcos women is unclear. the aim of this study is evaluating the effect of metformin administration on serum hcy levels and metabolic parameters of pcos patients. materi...